Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against Commvault Systems, Inc. (CVLT)
New York, New York--(Newsfile Corp. - February 16, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Commvault Systems, Inc. ("Commvault Systems, Inc.") (NASDAQ: CVLT) concerning potential violations of the federal securities laws. On January 27, 2026, Commvault reported financial results for the third quarter of fiscal 2026 ended December 31, 2025, including "40% growth in SaaS ARR to $364 million," as noted by the Company's Chief Accounting Officer...
2026-02-16 12:22 AM EST
STLA ACTIVE INVESTIGATION: Lost Money on Stellantis N.V.? Contact Levi & Korsinsky Now
New York, New York--(Newsfile Corp. - February 13, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Stellantis N.V. ("Stellantis N.V.") (NYSE: STLA) concerning potential violations of the federal securities laws. A review of the timeline highlights a sequence of signals that preceded the February 6 disclosure. On January 31, 2026, Wall Street Zen downgraded STLA to Sell. On February 3, Morgan Stanley followed with a downgrade to Equal-Weight, referencing...
2026-02-13 4:00 PM EST
Levi & Korsinsky Investigates Possible Securities Fraud by Coty Inc. (COTY)
New York, New York--(Newsfile Corp. - February 11, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Coty Inc. ("Coty Inc.") (NYSE: COTY) concerning potential violations of the federal securities laws. Coty's quarterly loss stands out within the global beauty and personal care sector, an industry that has generally posted resilient consumer demand over the past two years. Peers such as Estée Lauder, L'Oréal, and Shiseido reported stable or improving...
2026-02-11 1:19 PM EST
IT ALERT: Levi & Korsinsky Investigates Gartner, Inc. for Possible Securities Fraud Violations
New York, New York--(Newsfile Corp. - February 11, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Gartner, Inc. ("Gartner, Inc.") (NYSE: IT) concerning potential violations of the federal securities laws. SEC Regulation G and Item 10(e) of Regulation S-K establish disclosure requirements for companies presenting non-GAAP financial measures. These rules require that adjusted metrics be reconciled to the most directly comparable GAAP measure and that...
2026-02-11 8:53 AM EST
Levi & Korsinsky Launches Fraud Investigation on Behalf of monday.com Ltd. (MNDY) Shareholders
New York, New York--(Newsfile Corp. - February 10, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into monday.com Ltd. ("monday.com Ltd.") (NASDAQ: MNDY) concerning potential violations of the federal securities laws. On its February 9, 2026 earnings call, monday.com disclosed two specific headwinds that it had built into its 2026 guidance: persistent weakness in its "no-touch" performance marketing channel serving small and medium businesses, and a 100-200...
2026-02-10 3:20 PM EST
RAL ALERT: Ongoing Investigation Into Ralliant Corporation - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - February 10, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Ralliant Corporation ("Ralliant Corporation") (NYSE: RAL) concerning potential violations of the federal securities laws. On January 30, 2026--five days before revealing a $1.4 billion goodwill impairment and reduced FY 2026 guidance--Ralliant's board of directors declared a regular quarterly dividend of $0.05 per share. Dividend declarations are widely...
2026-02-10 1:24 PM EST
Commvault Systems, Inc. (CVLT) Under Investigation for Potential Securities Law Violations - Contact Levi & Korsinsky Today
New York, New York--(Newsfile Corp. - February 10, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Commvault Systems, Inc. ("Commvault Systems, Inc.") (NASDAQ: CVLT) concerning potential violations of the federal securities laws. On January 27, 2026, Commvault reported financial results for the third quarter of fiscal 2026 ended December 31, 2025, including "40% growth in SaaS ARR to $364 million," as noted by the Company's Chief Accounting Officer...
2026-02-10 11:34 AM EST
Levi & Korsinsky Investigates Possible Securities Fraud by Boston Scientific Corporation (BSX)
New York, New York--(Newsfile Corp. - February 10, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation (NYSE: BSX) ("Boston Scientific Corporation") concerning potential violations of the federal securities laws. On February 4, 2026, Boston Scientific reported fourth-quarter 2025 results. While the company exceeded analyst expectations for earnings per share and total revenue, its electrophysiology segment reported sales of...
2026-02-10 1:41 AM EST
Fraud Investigation Opened: Levi & Korsinsky Investigates Boston Scientific Corporation (BSX) on Behalf of Shareholders
New York, New York--(Newsfile Corp. - February 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation") (NYSE: BSX) concerning potential violations of the federal securities laws. On February 4, 2026, Boston Scientific reported fourth-quarter 2025 results. While the company exceeded analyst expectations for earnings per share and total revenue, its electrophysiology segment reported sales of $890...
2026-02-09 12:27 AM EST
Ongoing Investigation: REGENXBIO Inc. (RGNX) May Have Misled Shareholders - Levi & Korsinsky Investigates
New York, New York--(Newsfile Corp. - February 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into REGENXBIO Inc. ("REGENXBIO Inc.") (NASDAQ: RGNX) concerning potential violations of the federal securities laws. On January 28, 2026, Regenxbio disclosed via Form 8-K that the FDA placed clinical holds on its RGX-111 and RGX-121 programs following the identification of a tumor in a trial participant. The disclosure prompted a 30-35% decline in the company's...
2026-02-09 12:21 AM EST
Ongoing Securities Investigation into PayPal Holdings, Inc. (PYPL) - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - February 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into PayPal Holdings, Inc. ("PayPal Holdings, Inc.") (NASDAQ: PYPL) concerning potential violations of the federal securities laws. The timeline of analyst expectations and company communications reveals a notable trajectory. On January 28, 2026, Rothschild & Co Redburn issued a downgrade, cutting PayPal's price target to $50 from $70. The following day, Morgan...
2026-02-09 12:16 AM EST
ATTENTION CORT Investors: Securities Fraud Investigation Underway - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - February 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated") (NASDAQ: CORT) concerning potential violations of the federal securities laws. What Happened? On December 31, 2025, Corcept announced it received a CRL from the FDA, denying approval of Corcept's new drug application for relacorilant as a treatment for patients with hypertension...
2026-02-09 12:11 AM EST
Investors in Boston Scientific Corporation (BSX) Warned of Potential Securities Fraud - Contact Levi & Korsinsky Today
New York, New York--(Newsfile Corp. - February 5, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation") (NYSE: BSX) concerning potential violations of the federal securities laws. On February 4, 2026, Boston Scientific reported fourth-quarter 2025 results. While the company exceeded analyst expectations for earnings per share and total revenue, its electrophysiology segment reported sales of $890...
2026-02-05 1:34 PM EST
Lost Money on Gartner, Inc. (IT)? Contact Levi & Korsinsky About Investigation
New York, New York--(Newsfile Corp. - February 5, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Gartner, Inc. ("Gartner, Inc.") (NYSE: IT) concerning potential violations of the federal securities laws. SEC Regulation G and Item 10(e) of Regulation S-K establish disclosure requirements for companies presenting non-GAAP financial measures. These rules require that adjusted metrics be reconciled to the most directly comparable GAAP measure and that GAAP...
2026-02-05 12:52 PM EST
CVLT ALERT: Levi & Korsinsky Investigates Commvault Systems, Inc. for Possible Securities Fraud Violations
New York, New York--(Newsfile Corp. - February 5, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Commvault Systems, Inc. ("Commvault Systems, Inc.") (NASDAQ: CVLT) concerning potential violations of the federal securities laws. On January 27, 2026, Commvault reported financial results for the third quarter of fiscal 2026 ended December 31, 2025, including "40% growth in SaaS ARR to $364 million," as noted by the Company's Chief Accounting Officer...
2026-02-05 10:52 AM EST
ATTENTION PYPL Investors: Securities Fraud Investigation Underway - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - February 4, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into PayPal Holdings, Inc. ("PayPal Holdings, Inc.") (NASDAQ: PYPL) concerning potential violations of the federal securities laws. PayPal announced on February 3, 2026, a surprise leadership change, replacing Chief Executive Officer Alex Chriss. PayPal noted in its announcement "the pace of change and execution was not in line with the Board's expectations."...
2026-02-04 3:55 PM EST
Lost Money on Corcept Therapeutics Incorporated (CORT)? Possible Fraud - Contact Levi & Korsinsky Today
New York, New York--(Newsfile Corp. - February 4, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated") (NASDAQ: CORT) concerning potential violations of the federal securities laws. What Happened? On December 31, 2025, Corcept announced it received a CRL from the FDA, denying approval of Corcept's new drug application for relacorilant as a treatment for patients with hypertension...
2026-02-04 3:31 PM EST
Fraud Investigation: Levi & Korsinsky Investigates Ashford Hospitality Trust, Inc. (AHT) on Behalf of Shareholders
New York, New York--(Newsfile Corp. - February 3, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Ashford Hospitality Trust, Inc. ("Ashford Hospitality Trust, Inc.") (NYSE: AHT) concerning potential violations of the federal securities laws. Ashford issued a press release on January 13, 2026, "announcing that it has extended its Highland mortgage loan secured by 18 hotels" and that "to preserve the Company's liquidity position as it evaluates strategic...
2026-02-03 2:53 PM EST
Shareholders Alert: Investigation Into Aquestive Therapeutics, Inc. (AQST) - Contact Levi & Korsinsky to Protect Your Rights
New York, New York--(Newsfile Corp. - February 2, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Aquestive Therapeutics, Inc. ("Aquestive Therapeutics, Inc.") (NASDAQ: AQST) concerning potential violations of the federal securities laws. What Happened? On January 9, 2026, Aquestive announced it received a letter from the FDA, identifying deficiencies in its NDA application that preclude labeling discussions and post-market commitments for Anaphylm, for...
2026-02-02 12:26 AM EST
Did You Suffer Losses in First Western Financial, Inc. (MYFW)? Contact Levi & Korsinsky About Securities Fraud Claims
New York, New York--(Newsfile Corp. - February 2, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into First Western Financial, Inc. ("First Western Financial, Inc.") (NASDAQ: MYFW) concerning potential violations of the federal securities laws. First Western reported its financial results for the fourth quarter of 2025 on January 22, 2026. Among other items, the Company reported quarterly earnings of $0.34 per share, missing analyst expectations. Following...
2026-02-02 12:21 AM EST